EGFR and breast cancer: Moreover, Kaplan-Meier survival analysis showed that patients exhibiting high CXCR4, CCR7, and EGFR expression experienced a shorter survival period compared with those with low expression suggesting that these receptors can serve as an indicator of undesirable prognosis in patients with breast cancer [35].